StockData
ACHNYSEWholesale-Medical, Dental & Hospital Equipment & SuppliesFiscal year ends December 31

ACCENDRA HEALTH INC/VA/

Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 10, 2026
$0.22−0.01 (-6.30%)

Close on Oct 19, 2026

Market cap
$16.89M
P/E (TTM)
–
Dividend yield
–

About Accendra Health

Wholesale-Medical, Dental & Hospital Equipment & Supplies, SIC 5047

Accendra Health, Inc. provides medical supplies, technology, and home healthcare equipment across the United States. Its offerings focus on home respiratory therapy, obstructive sleep apnea treatment, diabetes care, wound care, and ostomy supplies. The company also delivers clinical support and patient management services designed to facilitate medical treatment outside acute care facilities. It operates primarily under brands such as Apria and Byram Healthcare, distributing products directly to individual patients as well as home health agencies. Reimbursement and payment arrangements involve commercial health insurers, managed care plans, state Medicaid programs, federal Medicare coverage, and direct out-of-pocket patient payments.

The company conducts nationwide operations across the United States and maintains medical gas facilities along with distribution centers across multiple states. At the end of 2025, the organization employed more than 6,500 full-time and part-time workers. Its corporate headquarters are located in Richmond, Virginia.

Summary of the business section of Accendra Health's latest annual report, written by StockData.

Company profile

Company

Legal name
ACCENDRA HEALTH INC/VA/
Founded
1882
Headquarters
Glen Allen, VA
Address
4435 Waterfront Drive, Suite 300
Phone
(804) 277-4304
Employees
6,500, Dec 31, 2025
Industry
Wholesale-Medical, Dental & Hospital Equipment & Supplies
Incorporated in
Virginia
Fiscal year ends
December 31
Auditor
KPMG, LLP, Richmond, VA

Stock & identifiers

Ticker
ACH
Exchange
NYSE
Shares outstanding
77M, Jun 30, 2026
Public float
$677.54M, Jun 30, 2025
Filer category
Large accelerated filer
Stock splits
3-for-2, Apr 1, 2010; 3-for-2, Jun 9, 1994; 3-for-2, Mar 23, 1993; 3-for-2, Jul 17, 1991; 3-for-2, Jun 1, 1988; 3-for-2, Sep 3, 1985; 2-for-1, Nov 1, 1982
SEC CIK
75252
CUSIP
690732102
ISIN
US6907321029
LEI
549300LMT5KQQXCEZ733
EIN
54-1701843

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
Edward A. PesickaPresident & CEO, Director1,072,785
Jonathan A. LeonEVP & CFO286,268
Heath H. GallowayEVP,General Counsel & CorpSecy166,306
Perry A. BernocchiEVP, Chief Operating Officer313,913
Andrew G. LongEVP, CEO P&HS448,425
Jennifer A. StoneEVP, CHRO110,327
Michael Wayne LowrySVP, Corporate Controller121,921
Stephen W. KlemashDirector90,242
Gwendolyn M. BinghamDirector22,184
Kenneth Gardner-SmithDirector86,113
Teresa L. KlineDirector85,316
Mark A. BeckDirector71,259
Carissa RollinsDirector53,902
Rita Johnson-MillsDirector54,125
Robert J. HenkelDirector77,412

CEO pay and shareholder return

Pay versus performance table from the proxy statement

Fiscal yearCEO total payCEO pay actually paidOther executives (avg)Value of $100 investedPeer group
FY2025
Edward A. Pesicka
$11.16M-$1.11M$3.05M$10$111
FY2024
Edward A. Pesicka
$10.74M$6.63M$3.01M$48$105
FY2023
Edward A. Pesicka
$8.39M$2.43M$3.27M$71$99
FY2022
Edward A. Pesicka
$6.25M-$20.49M$2.78M$72$94
FY2021
Edward A. Pesicka
$7.68M$42.84M$3.38M$161$121
FY2020
Edward A. Pesicka
$7.63M$56.61M$2.28M$524$126

“Actually paid” adjusts reported pay for changes in the value of equity awards. Shareholder return assumes $100 invested at the start of the measurement period, as disclosed by the company.

Employees

Headcount reported in annual reports

“At the end of 2025, following the sale of our Products & Healthcare Services segment (the “P&HS Sale”), we employed over 6,500 full-time and part-time teammates.”

Corporate history

Events identified from SEC filings

DateEventDetails
Oct 9, 2026Listing noticeNotice of delisting or failure to satisfy a listing rule (8-K Item 3.01)
Aug 10, 2026ListingRegistration of securities on an exchange (Form 8-A)
Dec 31, 2025Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Dec 31, 2025Name changeName changed from OWENS & MINOR INC/VA/ to ACCENDRA HEALTH INC/VA/
Mar 29, 2022Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 18, 2020Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Mar 4, 2019Late filingNotification of late filing
May 1, 2018Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jun 17, 2016DeregistrationTermination of SEC registration (Form 15)
Dec 14, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Oct 5, 2006Acquisition / saleCompletion of acquisition or disposition of assets (8-K Item 2.01)
Jul 13, 2004ListingRegistration of securities on an exchange (Form 8-A)
Oct 9, 2001DeregistrationTermination of SEC registration (Form 15)
Sep 10, 2001MergerRegistration of securities for a merger or exchange offer (S-4)
Jun 17, 1994Name changeName changed from O&M HOLDING INC to OWENS & MINOR INC/VA/
Jun 3, 1994DeregistrationTermination of SEC registration (Form 15)
Apr 5, 1994MergerRegistration of securities for a merger or exchange offer (S-4)
Mar 9, 1994Name changeName changed from OWENS & MINOR INC to O&M HOLDING INC